European Pharmaceutical Review

DECEMBER 1, 2023

During CPHI Barcelona, EPR Editor Caroline Peachey asked Anil Kane, Global Head of Technical & Scientific Affairs, Pharma Services, at Thermo Fisher Scientific about the dynamic landscape of pharmaceutical drug development. What are the trends affecting drug development today?

Drug Development 81

Drug Development Dosage Diabetes Process Improvement 81

pharmaphorum

JULY 8, 2022

The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial space. A recent Science 37 survey noted that nearly three-quarters (73%) of respondents from the pharma industry were planning a hybrid or DCT, up from 49% in 2021.

Drug Development 96

Drug Development Diabetes 96

pharmaphorum

OCTOBER 2, 2020

The five new NIHR National Patient Recruitment Centres (NPRCs) are set to shape the future of commercial clinical trials in the UK by offering new ways to conduct late-phase, large-scale research projects. How they will engage non-hospitalised patients with common chronic conditions.

Hospitals 92

Hospitals Diabetes 92

pharmaphorum

OCTOBER 2, 2020

The five new NHS Patient Recruitment Centres (NPRCs) are set to shape the future of commercial clinical trials in the UK by offering new ways to conduct late-phase, large-scale research projects. How they will engage non-hospitalised patients with common chronic conditions.

Hospitals 52

Hospitals Diabetes 52

Viseven

JULY 20, 2022

Imagine you wake up an omnichannel marketer in the middle of the night and ask: What does omnichannel strategy implementation start with ? Any decent omnichannel strategy requires proper target audience segmentation, and pharmaceutical marketing is no exception. What Does HCP Stands for in Pharma Marketing?

Communication 52

Communication Nursing Homes Hospitals 52

pharmaphorum

FEBRUARY 16, 2021

COVID-19 has disrupted markets and accelerated digital adoption but what does this mean for the future of marketing? In this feature, Grünenthal’s Florent Eduoard and Kate Hurtig outline their principles for a new pharmaceutical marketing model. . The R&D focus began to shift, and so did the marketing.

Health and Personal Care Stores 97

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Immunity 97